Celanese Corporation
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $124.87
- Today's High:
- $127.09
- Open Price:
- $125.64
- 52W Low:
- $85.0004
- 52W High:
- $156.2995
- Prev. Close:
- $125.99
- Volume:
- 1080634
Company Statistics
- Market Cap.:
- $12.39 billion
- Book Value:
- 52.038
- Revenue TTM:
- $9.99 billion
- Operating Margin TTM:
- 12.22%
- Gross Profit TTM:
- $2.38 billion
- Profit Margin:
- 14.85%
- Return on Assets TTM:
- 3.96%
- Return on Equity TTM:
- 27.11%
Company Profile
Celanese Corporation had its IPO on 2005-01-21 under the ticker symbol CE.
The company operates in the Basic Materials sector and Chemicals industry. Celanese Corporation has a staff strength of 13,263 employees.
Stock update
Shares of Celanese Corporation opened at $125.64 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $124.87 - $127.09, and closed at $125.99.
This is a 0% increase from the previous day's closing price.
A total volume of 1,080,634 shares were traded at the close of the day’s session.
In the last one week, shares of Celanese Corporation have slipped by -2.26%.
Celanese Corporation's Key Ratios
Celanese Corporation has a market cap of $12.39 billion, indicating a price to book ratio of 2.2163 and a price to sales ratio of 1.1566.
In the last 12-months Celanese Corporation’s revenue was $9.99 billion with a gross profit of $2.38 billion and an EBITDA of $1.74 billion. The EBITDA ratio measures Celanese Corporation's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Celanese Corporation’s operating margin was 12.22% while its return on assets stood at 3.96% with a return of equity of 27.11%.
In Q1, Celanese Corporation’s quarterly earnings growth was a negative -81.9% while revenue growth was a positive 12.4%.
Celanese Corporation’s PE and PEG Ratio
- Forward PE
- 7.3584
- Trailing PE
- 7.7154
- PEG
- 7.8465
Its diluted EPS in the last 12-months stands at $14.76 per share while it has a forward price to earnings multiple of 7.3584 and a PEG multiple of 7.8465. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Celanese Corporation’s profitability.
Celanese Corporation stock is trading at a EV to sales ratio of 1.4463 and a EV to EBITDA ratio of 5.0972. Its price to sales ratio in the trailing 12-months stood at 1.1566.
Celanese Corporation stock pays annual dividends of $2.76 per share, indicating a yield of 2.64% and a payout ratio of 22.46%.
Balance sheet and cash flow metrics
- Total Assets
- $26.09 billion
- Total Liabilities
- $3.85 billion
- Operating Cash Flow
- $-178000000.00
- Capital Expenditure
- $164 million
- Dividend Payout Ratio
- 22.46%
Celanese Corporation ended 2024 with $26.09 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $26.09 billion while shareholder equity stood at $5.66 billion.
Celanese Corporation ended 2024 with $1.22 billion in deferred long-term liabilities, $3.85 billion in other current liabilities, in common stock, $11.29 billion in retained earnings and $7.14 billion in goodwill. Its cash balance stood at $1.17 billion and cash and short-term investments were $1.17 billion. The company’s total short-term debt was $1,386,000,000 while long-term debt stood at $13.40 billion.
Celanese Corporation’s total current assets stands at $6.45 billion while long-term investments were $1.05 billion and short-term investments were $0. Its net receivables were $2.31 billion compared to accounts payable of $1.45 billion and inventory worth $2.75 billion.
In 2024, Celanese Corporation's operating cash flow was $-178000000.00 while its capital expenditure stood at $164 million.
Comparatively, Celanese Corporation paid $0.22 in dividends in 2024.
Other key metrics
- Current Trading Price
- $125.99
- 52-Week High
- $156.2995
- 52-Week Low
- $85.0004
- Analyst Target Price
- $124.07
Celanese Corporation stock is currently trading at $125.99 per share. It touched a 52-week high of $156.2995 and a 52-week low of $156.2995. Analysts tracking the stock have a 12-month average target price of $124.07.
Its 50-day moving average was $121.96 and 200-day moving average was $112.34 The short ratio stood at 3.43 indicating a short percent outstanding of 0%.
Around 34.6% of the company’s stock are held by insiders while 9691.3% are held by institutions.
Frequently Asked Questions About Celanese Corporation
Similar Industry Stocks (Chemicals)
Most Active
Top Gainers
Top Losers
About
Celanese Corporation, a chemical and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. The company operates through Engineered Materials and Acetyl Chain. The Engineered Materials segment develops, produces, and supplies specialty polymers for automotive and medical applications, as well as for use in industrial products and consumer electronics. It also offers acesulfame potassium for the food and beverage industry, and food protection ingredients, such as potassium sorbate and sorbic acid. The Acetyl Chain segment produces and supplies acetyl products, including acetic acid, vinyl acetate monomers, acetic anhydride, and acetate esters that are used as starting materials for colorants, paints, adhesives, coatings, and pharmaceuticals; and organic solvents and intermediates for pharmaceutical, agricultural, and chemical products. It also offers vinyl acetate-based emulsions for use in paints and coatings, adhesives, construction, glass fiber, textiles, and paper applications; and ethylene vinyl acetate resins and compounds, as well as low-density polyethylene for use in flexible packaging films, lamination film products, hot melt adhesives, automotive parts, and carpeting applications. In addition, it manufactures ultra-high molecular weight polyethylene. Celanese Corporation was founded in 1918 and is headquartered in Irving, Texas.